This article discusses the approval of misoprostol in Nigeria for the prevention of postpartum hemorrhage in 2006.
Nigeria has 2% of the world’s population, but 10% of the global burden of maternal deaths – a statistic that is described by Nigeria’s president Olusegun Obasanjo as “unacceptable and must be reversed”. In January 2006, Nigeria took an important step towards reversing this tragic situation when the Nigerian National Agency for Food and Drug Administration and Control approved the distribution of misoprostol for the prevention or treatment of postpartum haemorrhage (PPH). This is the first time misoprostol has been approved in any developed or developing country for this lifesaving indication.
Published in Journal of Family Planning and Reproductive Health Care, 32(4) 2006, 213-214
Download PDF, click here.